Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Development of Blood Vessels01:07

Development of Blood Vessels

1.6K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.6K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

7.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Veins of Head and Neck01:19

Veins of Head and Neck

6.4K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spesolimab for generalized pustular psoriasis: A prospective study with a 6-month-follow-up.

Clinical and experimental dermatology·2026
Same author

Clinicopathological and molecular characterization of tumor-associated macrophages in sporadic and Xeroderma Pigmentosum-related cutaneous melanoma.

BMC cancer·2026
Same author

Disseminated Kaposi sarcoma with cutaneous lesions on a surgical scar in a kidney transplant recipient.

Indian journal of dermatology, venereology and leprology·2026
Same author

Comparing the genetic and serum expression of LL-37 Antimicrobial Peptide in pemphigus vulgaris and pemphigus foliaceus patients.

Anais brasileiros de dermatologia·2026
Same author

Calcific Uremic Panniculitis: A Rare Form of Calciphylaxis in an Endstage Renal Disease Patient.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2025
Same author

Pseudochromhidrosis Presenting as Fuchsia Neck Discoloration.

International journal of dermatology·2025

Related Experiment Video

Updated: Mar 7, 2026

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
05:30

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

653

Congenital hemangioma.

Meriem Amouri1, Hela Mesrati1, Hend Chaaben1

  • 1Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia.

Cutis
|February 17, 2017
PubMed
Summary

Congenital hemangiomas (CHs), present at birth, include rapidly involuting (RICHs) and noninvoluting (NICHs) types. This study analyzed the epidemiology, characteristics, and outcomes of CHs in 6 infants.

Area of Science:

  • Pediatric Dermatology
  • Vascular Malformations

Background:

  • Congenital hemangiomas (CHs) are vascular tumors present at birth.
  • CHs are classified into rapidly involuting (RICHs) and noninvoluting (NICHs) subtypes.
  • Understanding CHs' clinical behavior is crucial for appropriate management.

Purpose of the Study:

  • To analyze the epidemiology of congenital hemangiomas.
  • To describe the clinical characteristics of CHs.
  • To evaluate the clinical outcomes of CHs in infants.

Main Methods:

  • Retrospective study conducted from 2008 to 2012.
  • Inclusion of 6 patients diagnosed with congenital hemangiomas.
  • Analysis of epidemiological data, clinical presentation, and patient outcomes.

More Related Videos

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.8K
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

1.1K

Related Experiment Videos

Last Updated: Mar 7, 2026

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
05:30

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

653
A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.8K
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

1.1K

Main Results:

  • The study included 6 patients (4 males, 2 females) with a mean age of 16 days.
  • Epidemiological factors, clinical features, and outcomes were documented.
  • Detailed analysis of RICHs and NICHs was performed over the 5-year study period.

Conclusions:

  • Congenital hemangiomas exhibit diverse clinical presentations and outcomes.
  • Further research is needed to fully elucidate the natural history of CHs.
  • This study provides insights into the early management of CHs.